CD8A and neoplasm: FACS analysis revealed that although tumor-associated CD8+ T cells and Treg cells were slightly increased upon anti-PD-1 treatment, the CD8+ /Treg ratio remained unchanged in comparison to the control antibody (Supplementary Fig. 1C).